Macrophages are versatile immune cells that act as sentinels, cleaners and regulators throughout the body. They originate from embryonic precursors and circulating monocytes, then adapt to the specific tissue environment. This local adaptation shapes their identity, function and lifespan, leading to distinct populations such as microglia in the brain, Kupffer cells in the liver, alveolar macrophages in the lungs and others in adipose tissue, heart and intestine.

Rather than a simple M1 versus M2 dichotomy, macrophage activation exists on a spectrum. Signals from pathogens, damaged cells and the tissue microenvironment determine their transcriptional programs. These programs involve key regulatory factors and metabolic pathways that tune macrophages toward inflammatory, reparative or regulatory roles.

In tissue repair, macrophages clear dead cells, orchestrate inflammation and then promote resolution and regeneration. Their timely transition from a pro inflammatory to a pro resolving state is crucial. Failure in this transition can lead to chronic inflammation and fibrosis.

In metabolic organs, macrophages help maintain homeostasis but can contribute to disease. In obesity, adipose tissue macrophages accumulate and adopt inflammatory phenotypes, interfering with insulin signaling and lipid handling. Similar principles apply in atherosclerosis where macrophages become foam cells and help drive plaque formation and instability.

Macrophages also interact closely with other cells, including stem and progenitor cells, shaping development and regeneration. Their plasticity makes them attractive therapeutic targets. Strategies include reprogramming harmful macrophages, enhancing reparative subsets or delivering drugs via macrophage specific pathways to treat inflammatory, metabolic, fibrotic and degenerative diseases.